Medicines for Europe is a leading brand in the pharmaceutical industry, representing the European Generics Medicines Association (EGA) and the biosimilar medicines sector. With over 20 years of experience, our association has evolved to meet the changing needs of the healthcare environment. We provide essential generic medicines that patients, healthcare professionals, and healthcare systems rely on to treat a wide range of acute and chronic diseases, including cardiovascular, diabetes, and cancer.

Our goal is to ensure better access to effective therapies, leading to improved patient outcomes and reduced healthcare inequalities. As technology advances, we have embraced innovation in the form of biosimilar medicines. These highly similar alternatives to existing biological medicines offer significant cost savings and positive patient experiences.

Furthermore, our expansion into value-added medicines aims to optimize existing treatments, addressing the unmet medical needs of patients and improving care delivery systems. Through our commitment to quality, value, sustainability, partnership, and patient-centered care, we continue to make significant contributions to Europe's healthcare system. Join us and become a member to support our mission in providing affordable and accessible medicines for all